Inventor · disambiguated record
Xiaoling Chen
Also filed as: CHEN XIAOLING
33 granted patents·9 pending applications·130 citations·filing 2004–2024
96Inventor score
Top patents by PatentIndex Score
42 records- 0197US11001561B2Pyrimidinone derivatives as SHP2 antagonistsMERCK PATENT GMBH·Filed 2020·Granted May 11, 2021·26 cites·19 claims
- 0291US10836750B1TLR7/8 antagonists and uses thereofMERCK PATENT GMBH·Filed 2020·Granted Nov 17, 2020·2 cites·17 claims
- 0391US8076486B2Heteroaryl-substituted arylaminopyridine derivatives as MEK inhibitorsGOUTOPOULOS ANDREAS·Filed 2007·Granted Dec 13, 2011·25 cites·21 claims
- 0489US9815836B2Macrocyclic compounds as IRAK1/4 inhibitors and uses thereofMERCK PATENT GMBH·Filed 2017·Granted Nov 14, 2017·7 cites·20 claims
- 0589US9624246B2Pyridazinone macrocycles as IRAK inhibitors and uses thereofMERCK PATENT GMBH·Filed 2016·Granted Apr 18, 2017·8 cites·14 claims
- 0688US9708324B2Macrocyclic compounds as IRAK1/4 inhibitors and uses thereofMERCK PATENT GMBH·Filed 2016·Granted Jul 18, 2017·7 cites·25 claims
- 0785US10947214B2TLR7/8 antagonists and uses thereofMERCK PATENT GMBH·Filed 2017·Granted Mar 16, 2021·2 cites·8 claims
- 0884US10793553B2TLR7/8 antagonists and uses thereofMERCK PATENT GMBH·Filed 2018·Granted Oct 6, 2020·2 cites·17 claims
- 0983US9580443B2Heterocyclic derivatives as modulators of kinase activityMERCK PATENT GMBH·Filed 2013·Granted Feb 28, 2017·5 cites·14 claims
- 1083US8569295B2Bicyclic urea compoundsCHEN XIAOLING·Filed 2010·Granted Oct 29, 2013·8 cites·60 claims
- 1182US9440968B2Substituted pyrido[3,2-d]pyrimidines for treating cancerMERCK PATENT GMBH·Filed 2013·Granted Sep 13, 2016·5 cites·14 claims
- 1282US8637532B2Amino azaheterocyclic carboxamidesSUTTON AMANDA E·Filed 2010·Granted Jan 28, 2014·9 cites·10 claims
- 1382US2024383876A1Tlr7/8 antagonists and uses thereofMERCK PATENT GMBH·Filed 2024·Application pending·0 cites
- 1480US9139568B2Heterocyclic carboxamides as modulators of kinase activityMERCK PATENT GMBH·Filed 2012·Granted Sep 22, 2015·4 cites·13 claims
- 1579US10517872B2Pyridazinone macrocycles as IRAK inhibitors and uses thereofMERCK PATENT GMBH·Filed 2017·Granted Dec 31, 2019·2 cites·16 claims
- 1679US9145392B2Imidazole amines as modulators of kinase activityLAN RUOXI·Filed 2012·Granted Sep 29, 2015·6 cites·26 claims
- 1778US9458134B2Heterocycles as modulators of kinase activityMERCK PATENT GMBH·Filed 2014·Granted Oct 4, 2016·3 cites·18 claims
- 1876US9321760B2Aminopyrimidine derivatives for use as modulators of kinase activityLAN RUOXI·Filed 2012·Granted Apr 26, 2016·3 cites·17 claims
- 1975US10080750B2Aminopyrimidine derivatives for use as modulators of kinase activityMERCK PATENT GMBH·Filed 2017·Granted Sep 25, 2018·1 cites·10 claims
- 2074US9040560B2Amino azaheterocyclic carboxamidesMERCK PATENT GMBH·Filed 2013·Granted May 26, 2015·2 cites·9 claims
- 2172US9662330B2Aminopyrimidine derivatives for use as modulators of kinase activityMERCK PATENT GMBH·Filed 2016·Granted May 30, 2017·1 cites·15 claims
- 2270US11702392B2Pyrimidinone derivatives as SHP2 antagonistsMERCK PATENT GMBH·Filed 2021·Granted Jul 18, 2023·0 cites·6 claims
- 2368US11512069B2TLR7/8 antagonists and uses thereofMERCK PATENT GMBH·Filed 2020·Granted Nov 29, 2022·0 cites·6 claims
- 2468US8735584B2Protein kinase inhibitors and use thereofHUCK BAYARD R·Filed 2009·Granted May 27, 2014·1 cites·2 claims
- 2568US2025144017A1Composition of oral soluble film and application thereofSHENZHEN RELX TECH CO LTD·Filed 2024·Application pending·0 cites
- 2666US2021002256A1Tlr7/8 antagonists and uses thereofMERCK PATENT GMBH·Filed 2020·Application pending·0 cites
- 2765US9434714B2Pyrimidine imidazole amines as modulators of kinase activityMERCK PATENT GMBH·Filed 2015·Granted Sep 6, 2016·1 cites·5 claims
- 2861US2009318438A1Heterocyclic compounds and their use as anticancer agentsCHEN XIAOLING·Filed 2008·Application pending·0 cites
- 2957US10287300B2Heterocyclic derivatives as modulators of kinase activityMERCK PATENT GMBH·Filed 2017·Granted May 14, 2019·0 cites·18 claims
- 3057US10233160B2Substituted pyrido[3,4-d]pyrimidines and pyrido[4,3-d]pyrimidines as p70S6K inhibitorsMERCK PATENT GMBH·Filed 2018·Granted Mar 19, 2019·0 cites·12 claims
- 3153US10087166B2Cyclic amine azaheterocyclic carboxamidesMERCK PATENT GMBH·Filed 2017·Granted Oct 2, 2018·0 cites·4 claims
- 3253US9850255B2Heterocyclic derivatives as modulators of kinase activityMERCK PATENT GMBH·Filed 2016·Granted Dec 26, 2017·0 cites·12 claims
- 3352US10080753B2Heterocyclic carboxamides as modulators of kinase activityMERCK PATENT GMBH·Filed 2016·Granted Sep 25, 2018·0 cites·5 claims
- 3452US9981925B2Substituted benzo[d][1,2,3]triazines as p70S6K inhibitorsMERCK PATENT GMBH·Filed 2016·Granted May 29, 2018·0 cites·12 claims
- 3552US2011269758A1Naphthyridinones as protein kinase inhibitorsMERCK PATENT GMBH·Filed 2009·Application pending·0 cites
- 3649US2009048301A1Heterocyclic compounds and their use as anticancer agentsIMCLONE SYSTEMS INC·Filed 2004·Application pending·0 cites
- 3748US9867826B2Heterocycles as modulators of kinase activityMERCK PATENT GMBH·Filed 2016·Granted Jan 16, 2018·0 cites·12 claims
- 3847US9586938B2Cyclic amine azaheterocyclic carboxamidesHUCK BAYARD R·Filed 2011·Granted Mar 7, 2017·0 cites·5 claims
- 3947US2016058763A1Novel heterocyclic carboxamides as modulators of kinase activityMERCK PATENT GMBH·Filed 2015·Application pending·0 cites
- 4045US9315517B2Imidazol-piperidinyl derivatives as modulators of kinase activityMERCK PATENT GMBH·Filed 2013·Granted Apr 19, 2016·0 cites·16 claims
- 4144US2021300940A1Tlr7/8 antagonists and uses thereofMERCK PATENT GMBH·Filed 2019·Application pending·0 cites
- 4241US2016000785A1Novel Imidazole Amines as Modulators of Kinase ActivityMERCK PATENT GMBH·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xiaoling Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →